Cancer Institute and Hospital,Chinese Academy of Medical Sciences
Cancer Institute and Hospital,Chinese Academy of Medical Sciences
Beijing, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM | malignant peritoneal mesothelioma | Recruiting | Phase 2 | 2024-08-07 | NCT06543069 |